We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RPTX market cap is 47.19M. The company's latest EPS is USD -1.9922 and P/E is -0.56.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.05M | 52.4M | 2.06M | 0 | 0 |
| Operating Income | -30.87M | 10.82M | -37.32M | -35.38M | -30.65M |
| Net Income | -28.03M | 13.16M | -34.77M | -34.41M | -28.67M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 135k | 7.6M | 131.83M | 51.13M | 53.48M |
| Operating Income | -54.3M | -108.66M | -19.8M | -116.22M | -93.52M |
| Net Income | -53.42M | -106.91M | -29.05M | -93.8M | -84.69M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 253.9M | 263.08M | 235.34M | 206.39M | 176.51M |
| Total Liabilities | 41.82M | 31.13M | 31.67M | 31.43M | 25.38M |
| Total Equity | 212.08M | 231.95M | 203.68M | 174.96M | 151.13M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 357.09M | 368.72M | 364.08M | 253.9M | 176.51M |
| Total Liabilities | 70.26M | 80.29M | 84.56M | 41.82M | 25.38M |
| Total Equity | 286.83M | 288.42M | 279.52M | 212.08M | 151.13M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -127.16M | 11.93M | -18.58M | -49.12M | -76.45M |
| Investing | 78.04M | -20.32M | -13.2M | 17.88M | 49.47M |
| Financing | 842k | 375k | 375k | 541k | 542k |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.08M | -85.8M | 322k | -127.16M | -76.45M |
| Investing | -9.76M | -1.68M | -175.78M | 78.04M | 49.47M |
| Financing | 247.84M | 95.56M | 880k | 842k | 542k |
| Market Cap | 47.19M |
| Price to Earnings Ratio | -0.56 |
| Price to Sales Ratio | 0.89 |
| Price to Cash Ratio | 0.56 |
| Price to Book Ratio | 0.32 |
| Dividend Yield | - |
| Shares Outstanding | 42.51M |
| Average Volume (1 week) | 193.36k |
| Average Volume (1 Month) | 181.95k |
| 52 Week Change | -78.53% |
| 52 Week High | 5.52 |
| 52 Week Low | 1.06 |
| Spread (Intraday) | 2.48 (70.86%) |
| Company Name | Repare Therapeutics Inc |
| Address |
7210 frederick-banting st., suite 100, saint-laurent saint-laurent, quebec H4S 2A1 |
| Website | https://www.reparerx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
